Eam Investors, LLC Kezar Life Sciences, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.58 - $17.13 $1.34 Million - $5.03 Million	-293,559 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$12.3 - $18.33 $600,264 - $894,540	-48,802 Reduced 14.25%	293,559 $4.88 Million
Q4 2021 Feb 11, 2022	BUY	$7.44 - $16.72 $2.55 Million - $5.72 Million	342,361 New	342,361 $5.72 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.